« Zurück
Startseite /
FRAT1 Antibody - C-terminal region

FRAT1 Antibody - C-terminal region

ArtNr	OAGA03593
Hersteller	AVIVA Systems Biology
Menge	100 ul
Kategorie	Oncology Neuroscience Neural Signaling Antibodies Immunohistochemistry Western Blot ELISA Immunofluorescence Immunocytochemistry Primary Antibodies By Organ Lymphatic System Cancer Immunochemistry
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	WB, IF, IHC, ICC
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host	Rabbit
Isotype	IgG
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Frequently rearranged in advanced T-cell lymphomas; FLJ97193;proto-oncogene FRAT1; FRAT-1
Versandbedingung	Gekühlt
Lieferbar
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Applications	ICC, IF, IHC-FFPE, WB
Manufacturer - Category	Root Catalog/Products/Polyclonal Antibodies, Root Catalog/Products/Primary Antibodies
Shipping Temperature	Wet Ice
Molecular Weight	29 kDa
Manufacturer - Application Additional Information	ICC: 1:100-1:1000 IF: 1:100-1:1000 IHC-FFPE: 1:100-1:1000 WB: 1:500-1:3000 Optimal dilutions should be determined by the end user.
Gene symbol	FRAT1
Gene Fullname	FRAT1, WNT signaling pathway regulator
Product format	Liquid. 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH 7). 0.01% Thimerosal was added as a preservative.
Reconstitution and storage	Keep as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4C. For long-term storage, aliquot and store at -20C or below. Avoid multiple freeze/thaw cycles.
Description of target	The protein encoded by this gene belongs to the GSK-3-binding protein family. The protein inhibits GSK-3-mediated phosphorylation of beta-catenin and positively regulates the Wnt signaling pathway. It may function in tumor progression and in lymphomagenesis.
Nucleotide accession_num	NM_005479.3
Protein accession_num	NP_005470.2
Protein name	proto-oncogene FRAT1
Clonality	Polyclonal
Purification	Purified by antigen-affinity chromatography.
Immunogen	Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human FRAT1. The exact sequence is proprietary.
Concentration	1 mg/ml

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

OAGA03593-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 100 ul

lieferbar

Lieferung vsl. bis 29.01.2026

Express-Lieferung: 9 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern